Chronic News and Research

RSS

Having “hasslers” in your network linked to faster aging and poorer health

Researchers analyzed a state-representative US sample to examine whether negative social ties, termed “hasslers,” are associated with epigenetic age acceleration and faster biological aging. Each additional hassler was linked to roughly nine months higher biological age and a 1.5% faster pace of aging, with particularly strong associations for mental health outcomes.

25 Feb 2026

No evidence connects tick bites to chronic health problems

When researchers studied Norwegians who thought tick bites caused their chronic health problems, they found no objective evidence linking the symptoms to ticks.

25 Feb 2026

Nearly 6 in 10 women in the U.S. may have cardiovascular disease in the next 25 years

Driven by rising rates in high blood pressure, nearly 6 in 10 women in the U.S. will have some type of cardiovascular disease (CVD) in the next 25 years, according to a new scientific statement published today in Circulation, the peer-reviewed, flagship journal of the American Heart Association, a global force changing the future of health for all.

25 Feb 2026

Social deprivation tied to less diverse gut microbiome

Living in a poorer neighborhood in the UK could impact the make-up of your gut microbiome, potentially leading to worse health.

25 Feb 2026

Democrats decry meager medical care for detainees in funding fight

Fernando Viera Reyes needed a biopsy for possible prostate cancer when the Trump administration sent him to an immigration detention center in California's Mojave Desert.

25 Feb 2026

Acute heart failure linked to high readmission and death rates

Almost half of patients hospitalized for acute heart failure in Europe are readmitted within a year, according to a new study led by researchers at Karolinska Institutet and published in the European Heart Journal.

25 Feb 2026

High-risk patients account for majority of postoperative deaths and readmissions

A major new study, led by Queen Mary University of London and funded by the National Institute for Health and Care Research (NIHR) has been published in The Lancet Public Health.

25 Feb 2026

SolasCure completes Phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, CLEANVLU2. The study demonstrated that its investigational product, Aurase Wound Gel (AWG), heals chronic wounds at a faster rate than current standard of care, providing clinical validation of its ability to deliver continuous enzymatic debridement while simultaneously activating wound healing.

24 Feb 2026

ARPA-H-funded PROSPR program focuses on the biological hallmarks of aging

Columbia University Mailman School of Public Health has received an award as part of the PROactive Solutions for Prolonging Resilience (PROSPR) program within the Advanced Research Projects Agency for Health (ARPA-H) to accelerate research on the biological hallmarks of aging.

24 Feb 2026

Parental obesity before conception raises offspring fatty liver risk

Pre-pregnancy parental overweight and obesity is linked to the next generation's heightened risk of developing fatty liver disease, a potential precursor to cirrhosis and liver failure, suggests research published online in the journal Gut.

24 Feb 2026

ATG14 found to be a critical defender against hepatic injury and fibrosis

Autophagy is indispensable for maintaining hepatocyte integrity, metabolic homeostasis, and survival. While several autophagy-related proteins have been studied in hepatic physiology, the specific role of Autophagy Related 14 (ATG14) in liver health has remained unclear.

24 Feb 2026

Swiss centenarians show youthful blood protein profiles in aging study

In Switzerland, 0.02% of the population lives beyond the age of 100. Could there be biological characteristics associated with this exceptional longevity? As part of the "SWISS100" study, the first large-scale Swiss research project dedicated to centenarians, a team from the University of Geneva (UNIGE) and the University of Lausanne (UNIL) compared the blood profiles of centenarians with those of octogenarians, and then with those of individuals aged 30 to 60.

24 Feb 2026

UCLA Health finds eco-friendly inhalers improve COPD outcomes

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly better patient outcomes. Inhalers are essential therapies for COPD and other lung conditions, but many commonly used devices rely on propellants that are potent greenhouse gases.

23 Feb 2026

Oxytocin circuits mediate sleep loss-induced social memory deficits

Social memory-the ability to recognize familiar individuals and distinguish them from strangers-is fundamental to social cognition.

23 Feb 2026

WashU Medicine receives 80 million to study exceptional longevity

Researchers at Washington University School of Medicine in St. Louis have received an $80 million grant to continue research into the mysteries of exceptional longevity.

23 Feb 2026

Osteoporosis drugs show promise against toxic iron accumulation

Researchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat diseases caused by iron accumulation in the body.

23 Feb 2026

Study links team creativity to lower clinician burnout

A new study from the Columbia University Mailman School of Public Health identifies team creativity as a powerful, measurable driver of well-being and effectiveness in primary care.

23 Feb 2026

Study captures real-time protein clumping linked to Alzheimer’s

An Oregon State University scientist and a team of undergraduate students have uncovered real-time insights into a chemical process linked with Alzheimer's disease, paving the way toward better drug designs.

23 Feb 2026

Five sessions a day TMS approach may reduce depression symptoms in one week

For the many patients with depression who haven't found relief through medication, transcranial magnetic stimulation (TMS) - a noninvasive therapy that uses magnetic pulses to stimulate specific areas of the brain - has become an increasingly important treatment option.

23 Feb 2026

As more Americans embrace anxiety treatment, MAHA derides medications

After a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Sadia Zapp was anxious — not the manageable hum that had long been part of her life, but something deeper, more distracting.

23 Feb 2026